← Leaderboards
David Gelmont
University Of Southern California
$191,317
Attributed
$191,317
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$191,317 · 3
By mechanism
M01$191,317 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- William J Jusko$16,823,605
- Daniel Arkfeld$347,081
- Brenda S Jones$382,634
- Carol W Wuenschell$442,144
- Zea Borok$23,656,539
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman Therapy EvaluationHuman SubjectAdult Respiratory Distress SyndromeDiagnostic Respiratory LavagePulmonary SurfactantsRespiratory Disorder ChemotherapySeptic ShockGrowth Factor ReceptorsBlood Disorder ChemotherapyAntiinflammatory AgentsImmunoglobulin GImmunotherapyMicroorganism Disease ChemotherapyNonsteroidal Antiinflammatory AgentPhospholipase A2Phospholipase InhibitorChimeric ProteinsChemotherapyDrug Screening /EvaluationTumor Necrosis Factor Alpha
Grant awards (9)
SMALL R BIG P SURFACTANT R SP-C FOR TREATMENT OF ARDS$0
M01 · FY2002 · RR
SMALL R BIG P SURFACTANT R SP-C FOR TREATMENT OF ARDS$155,764
M01 · FY2001 · RR
SMALL R BIG P SURFACTANT R SP-C FOR TREATMENT OF ARDS$0
M01 · FY2001 · RR
SMALL R BIG P SURFACTANT R SP-C FOR TREATMENT OF ARDS$35,553
M01 · FY2000 · RR
PHASE II STUDY OF LY315920 IN PATIENTS W SEVERE SEPSIS$0
M01 · FY2000 · RR
PHASE II STUDY OF LY315920 IN PATIENTS W SEVERE SEPSIS$0
M01 · FY2000 · RR
RO45-2081 IN TREATMENT OF SEVERE SEPSIS /SEPTIC SHOCK$0
M01 · FY2000 · RR
RO45-2081 IN TREATMENT OF SEVERE SEPSIS /SEPTIC SHOCK$0
M01 · FY2000 · RR
SMALL R BIG P SURFACTANT R SP-C FOR TREATMENT OF ARDS$0
M01 · FY2000 · RR